UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Bank of America
BAC
|
$190M |
| 2 |
Baidu
BIDU
|
$145M |
| 3 |
Kroger
KR
|
$137M |
| 4 |
LyondellBasell Industries
LYB
|
$135M |
| 5 |
Trane Technologies
TT
|
$129M |
Top Sells
| 1 |
Microsoft
MSFT
|
$253M |
| 2 |
Synchrony
SYF
|
$225M |
| 3 |
Amazon
AMZN
|
$196M |
| 4 |
AGN
Allergan plc
AGN
|
$169M |
| 5 |
CVS Health
CVS
|
$167M |
Sector Composition
| 1 | Financials | 15.05% |
| 2 | Technology | 14.96% |
| 3 | Healthcare | 13.85% |
| 4 | Consumer Discretionary | 9.89% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Pfizer
PFE
$141B
| $554M | 0.62% |
17,045,807
-404,370
| -2% | -$13.1M |
|
27
Walt Disney
DIS
$211B
| $544M | 0.61% |
5,216,029
-1,297
| -0% | -$135K |
|
28
Intel
INTC
$105B
| $538M | 0.6% |
14,829,568
-452,670
| -3% | -$16.4M |
|
29
Cisco
CSCO
$268B
| $512M | 0.57% |
16,929,171
-48,819
| -0.3% | -$1.48M |
|
30
IBM
IBM
$227B
| $498M | 0.56% |
3,000,906
-70,325
| -2% | -$11.7M |
|
31
Gilead Sciences
GILD
$140B
| $494M | 0.55% |
6,892,681
-1,018,180
| -13% | -$72.9M |
|
32
Comcast
CMCSA
$125B
| $489M | 0.55% |
7,074,673
-1,161,377
| -14% | -$80.2M |
|
33
Eli Lilly
LLY
$661B
| $471M | 0.53% |
6,406,387
+1,195,661
| +23% | +$87.9M |
|
34
Merck
MRK
$210B
| $467M | 0.52% |
7,938,160
-302,061
| -4% | -$17.8M |
|
35
Philip Morris
PM
$254B
| $467M | 0.52% |
5,102,772
-40,357
| -0.8% | -$3.69M |
|
36
Coca-Cola
KO
$297B
| $456M | 0.51% |
11,002,834
-218,860
| -2% | -$9.07M |
|
37
McDonald's
MCD
$226B
| $455M | 0.51% |
3,737,685
-251,746
| -6% | -$30.6M |
|
38
Citigroup
C
$175B
| $453M | 0.51% |
7,614,848
-127,204
| -2% | -$7.56M |
|
39
Mondelez International
MDLZ
$79.3B
| $428M | 0.48% |
9,647,461
-460,607
| -5% | -$20.4M |
|
40
Accenture
ACN
$158B
| $427M | 0.48% |
3,645,348
+25,957
| +0.7% | +$3.04M |
|
|
AGN
41
DELISTED
Allergan plc
AGN
| $418M | 0.47% |
1,990,239
-807,026
| -29% | -$169M |
|
42
Biogen
BIIB
$20.8B
| $415M | 0.47% |
1,463,392
-65,653
| -4% | -$18.6M |
|
43
Broadcom
AVGO
$1.42T
| $414M | 0.46% |
2,341,953
-682,093
| -23% | -$121M |
|
44
Amgen
AMGN
$153B
| $386M | 0.43% |
2,638,512
-598,979
| -19% | -$87.6M |
|
45
Oracle
ORCL
$628B
| $382M | 0.43% |
9,926,867
-32,608
| -0.3% | -$1.25M |
|
46
Starbucks
SBUX
$99.2B
| $381M | 0.43% |
6,865,996
-1,394,920
| -17% | -$77.4M |
|
47
TJX Companies
TJX
$155B
| $368M | 0.41% |
4,904,443
-1,452,052
| -23% | -$109M |
|
48
Altria Group
MO
$112B
| $355M | 0.4% |
5,245,862
-138,420
| -3% | -$9.36M |
|
49
AbbVie
ABBV
$374B
| $339M | 0.38% |
5,420,301
+296,622
| +6% | +$18.6M |
|
50
TAL Education Group
TAL
$6.34B
| $339M | 0.38% |
4,829,748
-107,800
| -2% | -$7.56M |
|